Provided by Tiger Fintech (Singapore) Pte. Ltd.

Assembly Biosciences

12.11
-0.2300-1.86%
Post-market: 11.65-0.4600-3.80%16:06 EDT
Volume:7.11K
Turnover:88.77K
Market Cap:90.87M
PE:-1.81
High:12.71
Open:12.41
Low:12.11
Close:12.34
Loading ...

Assembly Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Assembly Biosciences Q1 EPS $(1.17) Beats $(1.60) Estimate, Sales $9.42M Beat $7.63M Estimate

Benzinga
·
09 May

Assembly Biosciences announces preclinical data, to present at EASL Congress

TIPRANKS
·
07 May

Assembly Biosciences Inc expected to post a loss of $1.60 a share - Earnings Preview

Reuters
·
02 May

Assembly Biosciences (NASDAQ:ASMB) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.
·
02 May

Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress

GlobeNewswire
·
09 Apr

Down -22.6% in 4 Weeks, Here's Why Assembly Biosciences (ASMB) Looks Ripe for a Turnaround

Zacks
·
08 Apr

Assembly Biosciences (ASMB) Upgraded to Buy: What Does It Mean for the Stock?

Zacks
·
27 Mar

Assembly Biosciences Inc : Guggenheim Initiates Coverage With Buy Rating; Target Price $31

THOMSON REUTERS
·
25 Mar

Assembly Biosciences Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
22 Mar

BRIEF-Assembly Biosciences Inc Files For Mixed Shelf Offering Of Up To $250 Million

Reuters
·
21 Mar

BRIEF-Assembly Biosciences FY Net Income USD 40.177 Million

Reuters
·
21 Mar

Assembly Biosciences files $250M mixed securities shelf

TIPRANKS
·
21 Mar

Assembly Biosciences FY 2024 GAAP EPS $(6.69) Beats $(7.54) Estimate, Sales $28.520M Beat $26.838M Estimate

Benzinga
·
21 Mar

Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights

THOMSON REUTERS
·
21 Mar

Assembly Biosciences FY Income From Operations USD -45.42 Million

THOMSON REUTERS
·
21 Mar

Press Release: Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights

Dow Jones
·
21 Mar

Is Assembly Biosciences, Inc. (ASMB) Among Stocks With At Least $20 Million In Insider Spending Recently?

Insider Monkey
·
05 Mar

Assembly Biosciences Doses First Subject in Phase 1a Trial of Hepatitis Delta Virus Therapy Candidate; Shares Up

MT Newswires Live
·
26 Feb

Assembly Biosciences Doses First Participant in Phase 1a Clinical Study of Oral Entry Inhibitor Candidate Abi-6250 for Hepatitis Delta Virus

THOMSON REUTERS
·
26 Feb